MedTrace Logo

OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for Transplantation

NCT02522871 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2023-06-29

Study results available
· View outcomes & findings →

Summary

A prospective, phased-pivotal, international randomized trial to evaluate the effectiveness of the OCS™ Liver to preserve and assess donor livers intended for transplantation.

Conditions

  • Liver Transplantation
  • Liver Preservation for Transplant

Interventions

DEVICE

OCS™ Liver System

OTHER

Control

Sponsors & Collaborators

  • TransMedics

    lead INDUSTRY

Principal Investigators

  • Ahmed Elbetanony, MD · TransMedics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-24
Primary Completion
2019-10-22
Completion
2021-11-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02522871 on ClinicalTrials.gov